treated rats. L U s~b decreased from B. L. K by 22 f I**. 46 f 4**, and 40 f 6**, respectively. In PTH-treated r a t~,~O~p b decreased from B,L,K by 11 f 2*. 29 f 4** and 30 i 2**. Similar increases in the urinary excretion of calcium, phosphate and hydroxyproline were produced by both agents.
These in vivo data are consistent with previous in vitro o b s e~ vations. Moreover,PTH's dramatic effects on the redistribution of Pb in soft and hard tissues may well modify the toxic activities of Pb and thereby be of considerable clinical importance. Normal cardiac p-odrenergic fuwtion is important for maintenance of an intact stress respan& in the fetus and neonate. Propranolol (P), aP-adrenergic blocker is used to treat hypertension, arrhythmias and thyrotoxicosis i n pregnancy and appears to cross the placenta. To determine the effects of daily oral P administration on perinatal mortality and growth and cardiac P-receptor function in the fetus and neonate, we administered P i n a graded dosage schedule (5-20 mg/kg/day) to 20 Wistar rats on days 7-22 of pregnancy; 19 rats served as controls. 6 (3 controls) were delivered by caewrean section on day 22 for fetal studies. Neonates were studied at 0-12,24-36,4840 hours postpartum. There were no differences (p>0.05) between P and control rats i n maternal weight gain, litter size, number of rewrption sites and stillbirths, ond pup size and heart weight. Cardiacpreceptor function was studied by recording spontaneous rates of impulse initiation of isolated right atriol strips during control superfusion withTyrode's wlution and following superfusion with epinephrine (E), 1 x 1 0 -5~. E induced a significant rate increase i n atria from the controls (p<.01). Norate change (P>.05) was seen i n atria from fetuses of P-treated mothers. As age increased to 60 hours postpartum the respanre to E of P-treated neonates increased. By 48-60 hours this did not differ significantly from control .Hence chronic P administration significantly depresses b-responsiwness of fetal 8 newborn rat hearts which could be potentially dangerous to the fetus in his adaptation to the stresses of labor. Blood pressure of NC-D and NC-V were similar. Pulse rate was similar. Vasomotor reactivity was studied at 12 weeks by hindquarter vascular resistance. Though SHR-V developed high vascular resistance (VR).
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VR in SHR-D was reduced (p<.05), the VR of NC-D and NC-V were similar. The change in vascular resistance to norepinephrine (NE), epinephrine (E), barium chloride (BaC12) Cardiac glycosides are known to inhibit spontaneous and induced human cell division. We have studied a large number of genin and glycoside congeners to determine (a) whether the saccharide or genin portion of the molecule contributes to its antimitotic effect, (b) whether the antimitotic effect is correlated with inhibition of ~a + K+ ATPase activity, and (c) whether antimitotic effects can be dissociated from cardiac arrhythmigenicity. The concentratinn of glycoside required to inhibit PHA stimulated thymidine incorporation into DNA at 72 hours in human lymphocytes was studied. The 50% inhibitory dose could be varied by greater than 10-fold by a change in either the genin or the saccharide. Therefore, both genin and saccharide were related to the antimitotic effect of the glycosides. The effect of varying genin or saccharide and the dose-inhibitionqcurves indicated that the antimitotic effect was qualitatively similar to the known effects of these drugs on ATPase activity. Cardiac glycosides were much more potent and rapidacting inhibitors of lymphoproliferation in vitro than glucocorticoids. The antimitotic effects of moat of the agents studied appeared to be at concentrations which have a very high risk for arrhythmigenicity of the myocardium. However, these studies may provide incentive to explore structural variants of cardiac glycosides as pharmacologic agents to inhibit cell division. Since closure o f i h e f e t a l ductus arteriosus can be accomplished near term by maternal indomethacin dnd s a l i c y l a t e administration, an animal model was devised t o study the p o s s i b i l i t y of brain damage through a l t e r a t i o n o f f e t a l hemodynamics. Pregnant S-D r a t s on d 18. 19 and/or 20 received sc e i t h e r 100 mg/kg sodium s a l i c y l a t e (13 rats). 5 mg/kg indomethacin (6 r a t s ) o r vehiclecontrols) i n a single b l i n a u d . Dams were sacrif i c e d p r i o r t o onset o f labor a t term (d 2 1 j and u t e r i i were examined f o r s t i l l b i r t h s and resorbtions. Surviving pups were f i x e d i n Bouin's solu. and diencephalon sections were quantitat i v e l y graded f o r neuronal necrosis as per method o f Ornoy and GPA (AJOG 124: 196.1976 ). Indo produced severe changes and sal mod-severe e f f e c t s when compared t o vehicle treatment. Control dams had no s t i l l b i r t h s while indo and sal groups had s t i l l b i r t h s i n 2 and 3 l i t t e r s respectively.fhe n e E n a l damage and s t i l lb i r t h s may be mediated v i a the constrictor e f f e c t o f prostaglandin synthetase i n h i b i t o r s and sal) on the f e t a l ductus, a d i r e c t neuronal toxic o r both. The hypoxia and respirat o r y acidosis i n pups and infants surviving maternal Indo t r e a tment i s f u r t h e r evidence t h a t t h i s class o f drugs can influence neonatal hemodynamics (Prostaglandins 8:363,1974 Maternal i n e t i n o s i h i b i ors whether y s e l f med i t i o n o r pres@rlpL?on f i n i F k i t l o n o f p a r t u n t i o n ? may contribute t o adverse perinatal events. Minimal Brain Dysfunction (MBD) is one of the most prevalent problems in present day pediatrics affecting an estimated 5-10% of the school age population. Recent evidence from several lines of investigation support the notion that brain catecholamines are involved in the basic pathophysiologic mechanisms of MBD. In order to explore these mechanisms in more detail, we have produced an experimental model of MBD in the developing rat pup that has many of the similarities of the clinical disorder found in children. The model is effected by the intracisternal administration of 6-hydroxydopamine (6-OHDA) in the 5 day old rat pup, resulting in a rapid and permanent reduction of brain dopamine to values less than 50% of controls. Treated rat pups develop hyperactivity which abates with maturity and persistent learning deficits. We now report the effects of methylphenidate (0.25-2.0mgI kg) on activity levels at 12,19 and 26 days and T-maze learning at 20 days of age. Methylphenidate significantly increased activity levels and had no effect on T-maze learning in normals. In contrast methylphenidate reduced activity and significantly improved T-maze performance in 6-OHDA treated animals. Our results suggest that the "paradoxical" response to methylphenidate found in 6-OHDA treated rat pups may result from central denervation supersensitivity.
